These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 16492145

  • 1. Peptide, peptidomimetic and small-molecule drug discovery targeting HIV-1 host-cell attachment and entry through gp120, gp41, CCR5 and CXCR4.
    Kazmierski WM, Kenakin TP, Gudmundsson KS.
    Chem Biol Drug Des; 2006 Jan; 67(1):13-26. PubMed ID: 16492145
    [Abstract] [Full Text] [Related]

  • 2. Inhibitors of the entry of HIV into host cells.
    Meanwell NA, Kadow JF.
    Curr Opin Drug Discov Devel; 2003 Jul; 6(4):451-61. PubMed ID: 12951808
    [Abstract] [Full Text] [Related]

  • 3. Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D).
    Marozsan AJ, Kuhmann SE, Morgan T, Herrera C, Rivera-Troche E, Xu S, Baroudy BM, Strizki J, Moore JP.
    Virology; 2005 Jul 20; 338(1):182-99. PubMed ID: 15935415
    [Abstract] [Full Text] [Related]

  • 4. Sensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptor.
    Derdeyn CA, Decker JM, Sfakianos JN, Zhang Z, O'Brien WA, Ratner L, Shaw GM, Hunter E.
    J Virol; 2001 Sep 20; 75(18):8605-14. PubMed ID: 11507206
    [Abstract] [Full Text] [Related]

  • 5. Progress in targeting HIV-1 entry.
    Ryser HJ, Flückiger R.
    Drug Discov Today; 2005 Aug 15; 10(16):1085-94. PubMed ID: 16182193
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Blocking HIV entry.
    Buzko OV, Shokat KM.
    Nat Struct Biol; 1999 Oct 15; 6(10):906-8. PubMed ID: 10504719
    [Abstract] [Full Text] [Related]

  • 8. HIV entry inhibitors: progress in development and application.
    Lai WH, Huang L, Chen CH.
    Yao Xue Xue Bao; 2010 Feb 15; 45(2):131-40. PubMed ID: 21348414
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of HIV-1 infection by synthetic peptides derived CCR5 fragments.
    Imai M, Baranyi L, Okada N, Okada H.
    Biochem Biophys Res Commun; 2007 Feb 23; 353(4):851-6. PubMed ID: 17210123
    [Abstract] [Full Text] [Related]

  • 10. Resistance profile of a neutralizing anti-HIV monoclonal antibody, KD-247, that shows favourable synergism with anti-CCR5 inhibitors.
    Yoshimura K, Shibata J, Kimura T, Honda A, Maeda Y, Koito A, Murakami T, Mitsuya H, Matsushita S.
    AIDS; 2006 Oct 24; 20(16):2065-73. PubMed ID: 17053352
    [Abstract] [Full Text] [Related]

  • 11. Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.
    Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.
    Cell; 2007 Apr 20; 129(2):263-75. PubMed ID: 17448989
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. HIV chemokine receptor inhibitors as novel anti-HIV drugs.
    Princen K, Schols D.
    Cytokine Growth Factor Rev; 2005 Dec 20; 16(6):659-77. PubMed ID: 16005254
    [Abstract] [Full Text] [Related]

  • 16. Discovery of 4-benzoyl-1-[(4-methoxy-1H- pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2- (R)-methylpiperazine (BMS-378806): a novel HIV-1 attachment inhibitor that interferes with CD4-gp120 interactions.
    Wang T, Zhang Z, Wallace OB, Deshpande M, Fang H, Yang Z, Zadjura LM, Tweedie DL, Huang S, Zhao F, Ranadive S, Robinson BS, Gong YF, Ricarrdi K, Spicer TP, Deminie C, Rose R, Wang HG, Blair WS, Shi PY, Lin PF, Colonno RJ, Meanwell NA.
    J Med Chem; 2003 Sep 25; 46(20):4236-9. PubMed ID: 13678401
    [Abstract] [Full Text] [Related]

  • 17. A synthetic heparan sulfate-mimetic peptide conjugated to a mini CD4 displays very high anti- HIV-1 activity independently of coreceptor usage.
    Connell BJ, Baleux F, Coic YM, Clayette P, Bonnaffé D, Lortat-Jacob H.
    Chem Biol; 2012 Jan 27; 19(1):131-9. PubMed ID: 22284360
    [Abstract] [Full Text] [Related]

  • 18. What's in the works.
    Horn T.
    Posit Living; 2001 Feb 27; 10(2):20-2. PubMed ID: 11548496
    [No Abstract] [Full Text] [Related]

  • 19. HIV entry inhibitors: mechanisms of action and resistance pathways.
    Briz V, Poveda E, Soriano V.
    J Antimicrob Chemother; 2006 Apr 27; 57(4):619-27. PubMed ID: 16464888
    [Abstract] [Full Text] [Related]

  • 20. Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.
    Zhao Q, Ma L, Jiang S, Lu H, Liu S, He Y, Strick N, Neamati N, Debnath AK.
    Virology; 2005 Sep 01; 339(2):213-25. PubMed ID: 15996703
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.